IndraLab

Statements


YOD1-C160S leads to the deubiquitination of TRAF6. 1 / 1
| 1

reach
"Also, catalytically inactive YOD1 C160S impaired the boost of TRAF6 auto-ubiquitination by p62, even though the inhibition was not quite as severe as with YOD1 WT."